Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

391 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implications.
Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV, Radeke MJ, Kavanagh D, Richards A, Atkinson J, Meri S, Bergeron J, Zernant J, Merriam J, Gold B, Allikmets R, Dean M. Hageman GS, et al. Among authors: meri s. Ann Med. 2006;38(8):592-604. doi: 10.1080/07853890601097030. Ann Med. 2006. PMID: 28950782 Free article.
Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein.
Laine M, Jarva H, Seitsonen S, Haapasalo K, Lehtinen MJ, Lindeman N, Anderson DH, Johnson PT, Järvelä I, Jokiranta TS, Hageman GS, Immonen I, Meri S. Laine M, et al. Among authors: meri s. J Immunol. 2007 Mar 15;178(6):3831-6. doi: 10.4049/jimmunol.178.6.3831. J Immunol. 2007. PMID: 17339482 Free PMC article. Clinical Trial.
Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.
Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV, Radeke MJ, Kavanagh D, Richards A, Atkinson J, Meri S, Bergeron J, Zernant J, Merriam J, Gold B, Allikmets R, Dean M; AMD Clinical Study Group. Hageman GS, et al. Among authors: meri s. Ann Med. 2006;38(8):592-604. Ann Med. 2006. PMID: 17438673 Free PMC article.
Complement activation and HLA-B27.
Meri S, Partanen J, Leirisalo-Repo M, Repo H. Meri S, et al. Ann Rheum Dis. 1988 Mar;47(3):210-4. doi: 10.1136/ard.47.3.210. Ann Rheum Dis. 1988. PMID: 3258504 Free PMC article.
Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.
Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz HU, Meri S, Rose NR, Salant DJ, Sethi S, Smith RJ, Smoyer W, Tully HF, Tully SP, Walker P, Welsh M, Würzner R, Zipfel PF. Appel GB, et al. Among authors: meri s. J Am Soc Nephrol. 2005 May;16(5):1392-403. doi: 10.1681/ASN.2005010078. Epub 2005 Mar 30. J Am Soc Nephrol. 2005. PMID: 15800116 Review.
New approaches to the treatment of dense deposit disease.
Smith RJ, Alexander J, Barlow PN, Botto M, Cassavant TL, Cook HT, de Córdoba SR, Hageman GS, Jokiranta TS, Kimberling WJ, Lambris JD, Lanning LD, Levidiotis V, Licht C, Lutz HU, Meri S, Pickering MC, Quigg RJ, Rops AL, Salant DJ, Sethi S, Thurman JM, Tully HF, Tully SP, van der Vlag J, Walker PD, Würzner R, Zipfel PF; Dense Deposit Disease Focus Group. Smith RJ, et al. Among authors: meri s. J Am Soc Nephrol. 2007 Sep;18(9):2447-56. doi: 10.1681/ASN.2007030356. Epub 2007 Aug 5. J Am Soc Nephrol. 2007. PMID: 17675665 Free PMC article. Review.
391 results